HNGE Hinge Health, Inc.
Services-Computer Processing & Data Preparation · NYSE · SEC CIK 1673743 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY49.9%
TTM net income YoY131.6%
TTM EPS YoY146.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin85.7%
Operating margin18.7%
Net margin21.0%
FCF margin40.2%
EBITDA margin19.1%
Returns
ROE66.3%
ROA20.5%
ROIC (approx.)869.6%
Asset turnover0.97x
Leverage & solvency
Liabilities / assets65.7%
Debt / equity0.00x
Current ratio1.04x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.92x
Accruals ratio-18.8%
Payout ratio—
Capex / revenue0.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $234.97M | $212.82M | $182.31M | $170.73M | $154.21M | $139.10M | $123.83M | $117.26M |
| Cost of revenue | $30.64M | $28.87M | $28.07M | $26.70M | $28.01M | $41.34M | $23.59M | $21.17M |
| Gross profit | $204.33M | $183.95M | $154.23M | $144.03M | $126.20M | $97.76M | $100.23M | $96.09M |
| R&D expense | $37.47M | $34.06M | $30.34M | $32.76M | $31.92M | $279.96M | $23.50M | $22.37M |
| SG&A expense | $31.29M | $28.04M | $23.02M | $24.53M | $36.85M | $251.24M | $16.88M | $17.36M |
| Operating income | $50.33M | $40.44M | $32.07M | $27.26M | -$6.09M | -$580.67M | $13.14M | $20.91M |
| Pretax income | $53.72M | $44.43M | $35.94M | $32.22M | -$1.64M | -$575.98M | $18.14M | $26.16M |
| Income tax | -$3.68M | $740,000 | $814,000 | $122,000 | $206,000 | -$326,000 | $998,000 | -$951,000 |
| Net income | $57.40M | $43.69M | $35.13M | $32.09M | -$1.84M | -$575.65M | $17.14M | $27.12M |
| EBITDA | $50.52M | $40.64M | $33.24M | $28.48M | -$5.79M | -$580.37M | $14.44M | $22.28M |
| EPS (basic) | 0.71 | 0.55 | 0.43 | — | -0.02 | -13.10 | 7.91 | — |
| EPS (diluted) | 0.66 | 0.52 | 0.41 | — | -0.02 | -13.10 | 1.31 | — |
| Weighted avg. shares (diluted) | 86.53M | 83.42M | 82.39M | — | 78.86M | 43.93M | 92.75M | — |
| Banking | ||||||||
| Provision for credit losses | $914,000 | $1.61M | $0 | -$279,000 | $560,000 | $1.89M | $886,000 | $1.47M |
| Balance sheet | ||||||||
| Cash & equivalents | $211.55M | $286.22M | $186.67M | $208.00M | $261.34M | $237.17M | $288.48M | $302.59M |
| Short-term investments | $83.10M | $103.17M | $129.20M | $155.87M | $218.69M | $176.09M | — | $165.79M |
| Receivables | $148.53M | $125.43M | $114.92M | $66.06M | $86.77M | $99.30M | — | $42.49M |
| Inventory | $19.19M | $16.77M | $14.17M | $15.64M | $13.81M | $13.99M | — | $10.87M |
| Current assets | $567.86M | $643.35M | $540.05M | $533.90M | $658.88M | $598.42M | — | $583.45M |
| PP&E, net | $13.99M | $12.74M | $11.35M | $10.49M | $8.40M | $7.72M | — | $7.38M |
| Goodwill | $113.03M | $64.10M | $64.10M | $64.10M | $64.10M | $64.10M | — | $61.61M |
| Intangibles | $68.33M | $2.06M | $2.29M | $2.51M | $2.74M | $2.96M | — | $1.81M |
| Total assets | $874.08M | $827.40M | $728.77M | $744.76M | $769.80M | $693.65M | — | $673.26M |
| Current liabilities | $544.71M | $481.44M | $414.48M | $362.41M | $357.08M | $314.08M | — | $249.30M |
| Total liabilities | $574.66M | $483.07M | $417.21M | $366.23M | $361.93M | $320.00M | — | $256.56M |
| Shareholders' equity | $299.42M | $344.33M | $111.69M | $178.66M | $208.00M | $173.78M | -$308.28M | -$434.57M |
| Shares outstanding | — | — | — | 0 | 0 | 0 | — | 16.38M |
| Cash flow statement | ||||||||
| Operating cash flow | $114.60M | $101.41M | $43.08M | $63.89M | $82.40M | $20.23M | $4.92M | $38.34M |
| Capital expenditure | $376,000 | $123,000 | $83,000 | $408,000 | $52,000 | $197,000 | $51,000 | $157,000 |
| Free cash flow | $114.23M | $101.29M | $43.00M | $63.48M | $82.35M | $20.03M | $4.87M | $38.18M |
| Investing cash flow | -$64.18M | $28.62M | $48.08M | -$37.70M | -$58.76M | $4.02M | -$21.33M | -$3.11M |
| Financing cash flow | -$122.26M | -$30.48M | -$112.85M | -$79.55M | $531,000 | -$75.56M | $4.10M | -$2.33M |
| Depreciation & amortization | $200,000 | $200,000 | $1.17M | $1.22M | $300,000 | $300,000 | $1.30M | $1.37M |
| Stock-based compensation | $19.54M | $19.09M | $11.69M | $17.17M | $34.85M | $590.98M | $7,000 | $14,000 |
| Share buybacks | $25.89M | $26.52M | $104.97M | $65.03M | $0 | $0 | $0 | — |
Free plan shows the latest 8 periods; Pro shows all 11 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.